Latest Updates on Minimal Residual Disease (MRD)

Thursday, July 22nd
11:00 AM - 12:00 PM (ET)


Join us for a FREE webinar on minimal residual disease (MRD).  Our faculty will review the importance of MRD for multiple myeloma patients, explain how MRD is measured, and discuss current clinical strategies used to help patients reach MRD negative status. This webinar provides timely information to keep patients and caregivers up to date on the important progress being made in myeloma today, helping them communicate more effectively with their health care team, and empowering them to achieve the best possible outcome for their disease.  



Latest Updates on Minimal Residual Disease (MRD)

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt.

MMRF Webinar:
Latest Updates on Minimal Residual Disease (MRD)


Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain in the body after treatment.  Drs. Fonseca and Shah will outline data describing the use of MRD in clinical trials and what you need to discuss with your healthcare team.   

 During this event, you will: 

  • Hear how minimal residual disease is measured 
  • Listen to the experts discuss the science supporting the importance of achieving negative MRD status 
  • Learn how MRD measurement may be used for future monitoring of how effective a treatment is 
  • Be able to send the experts your questions related to minimal residual disease